$SOFSF: CLEANGO INNOVATIONS INC. Provides an Update on the

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
166
$SOFSF: CLEANGO INNOVATIONS INC. Provides an Update on the Previously Mentioned Letter of Intent / Distribution Agreement with the German Distributor and Proposed Private Placement
(via TheNewswire)

Vancouver BC –TheNewswire -July 12, 2022 -CleanGo Innovations Inc. (CSE:CGII) (CNSX:CGII.CN) (OTC:SOFSF) (FRA:APO2) CleanGo Innovations Inc. (“CleanGo” or the “Company) is pleased to announce an update regarding its letter of intent with HAST.


In April of this year, CleanGo hosted the HAST management team in Houston, Texas. At these meetings, CleanGo showcased their new 10,000 sq ft Houston facility and the groups discussed the benefits of the new facility to both companies.


These discussions prompted further meetings in Hamburg, Germany in June. At this meeting, CleanGo and HAST discussed the terms of an agreement between the two companies, and the parties have now commenced working on a finalized definitive agreement.


Anthony Sarvucci, CEO of CleanGo, said. “It was our honor to host the team from HAST in Houston, the group is a great fit to our business model as we believe we are to theirs. My recent trip to Hamburg was equally felt, we were able to discuss the product lines that complement our businesses from both sides moving forward and we look forward to a long and fruitful relationship between our two companies” CleanGo Innovations looks forward to sharing the details and clarity of our arrangement in the coming weeks.

CleanGo would also like to announce a proposed private placement of up to 750,000 units (“Units”) at a price of $0.40 per Unit for gross proceeds of $300,000 (the “Offering”). Each Unit consists of one common share in the capital of CleanGo and one-half of one Common Share purchase warrant (the “Warrant”). Each whole Warrant is entitled to acquire one Common Share at an exercise price of $0.60 for a period of 18 months from issuance. The Warrants will be subject to an acceleration clause if the trading price of the Common Shares is greater than $0.85 for a period of ten consecutive days. Proceeds of the Offering will be used for working capital purposes.

About CleanGo Innovations

CleanGo Innovations Inc. is an international publicly traded ESG company that is revenue generating and specialized in the development of early staged, green, non-toxic and sustainable technology companies. We provide access to capital, executive management and industry experience to grow our portfolio of companies.

CleanGo Innovations experienced team bring new ideas and innovation based on science to find solutions to the current world we live in, CleanGo products cover a vast array of situations including Retail, Commercial and Industrial Solutions. Customers rely on quality, nontoxic, Green Certified products to keep their homes clean and their loved ones safe. For more information visit our website: https://cleangogreengo.comorwww.cleangoinnovations.com


On behalf of the CEO & Board of Directors

Anthony SarvucciChief Executive Officer CleanGo Innovations Inc.anthony@cleangogreengo.com


Paul Searle

Investor Relations

1 778 240 7724


NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Forward-looking Information

This news release may contain forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian and U.S. securities legislation. Forward-looking statements can often be identified by words such as “will”, “plans”, “expects”, “may”, “intends”, “anticipates”, “believes”, proposes” or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. Actual results could differ from those projected in any forward-looking statements due to numerous factors, including risks and uncertainties relating to general economic, market or business conditions or changes in laws, regulations and policies affecting the Company’s operations. Investors are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. Any forward-looking statements included in this news release are made as of the date hereof and the Company does not intend to update or revise any forward-looking statements, except as expressly required by law.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading

Top 5 Most Recently Viewed Articles

NVIDIA and Synopsys Forge Alliance to Transform Engineering

Updated Category News Views 137

Strategic Collaboration Between NVIDIA and Synopsys In an exciting development for the engineering and design industries, NVIDIA and Synopsys have joined forces in a strategic partnership that promises to revolutionize how these sectors operate. This collaboration aims to leverage NVIDIA's powerful computational capabilities alongside Synopsys' sophisticated engineering...

Continue Reading
EHang's Groundbreaking Pilotless Flight Marks a Historic Event

Updated Category News Views 110

EHang's Historic Pilotless Flight in Africa EHang Holdings Limited (Nasdaq: EH), a frontrunner in Urban Air Mobility (UAM), has made headlines by achieving a remarkable milestone: the first pilotless human-carrying flight of its EH216-S eVTOL aircraft in Africa. This significant event unfolded at the 9th Aviation Africa Summit in Kigali, marking a historic moment for the...

Continue Reading
Bang & Olufsen's Share Buyback: Strategic Moves for Growth

Updated Category News Views 112

Understanding Bang & Olufsen's Share Buyback Program Bang & Olufsen A/S has embarked on a significant initiative aimed at bolstering its long-term growth through its recent share buyback program. This strategic move is designed to hedge the company’s share-based long-term incentive programmes, showcasing their commitment to enhancing shareholder value. This article...

Continue Reading
Johnson & Johnson's Q2 Expectations and Analyst Ratings Insights

Updated Category News Views 275

Upcoming Earnings Announcement for Johnson & Johnson Johnson & Johnson (NYSE: JNJ) is preparing to disclose its earnings results for the upcoming second quarter. Analysts are closely watching the anticipated report, which is expected to provide valuable insights into the company's financial health. Expected Financial Performance Analyst forecasts suggest that Johnson &...

Continue Reading
Safe House Project Expands Impact with ATI Acquisition

Updated Category News Views 307

Safe House Project Expands Impact with ATI Acquisition This Giving Tuesday, the Safe House Project (SHP) shared exciting news about its acquisition of Anti-Trafficking International (ATI), an organization that has been pivotal in the fight against human trafficking. By incorporating ATI's respected practices and its renowned Just Ask Prevention Curriculum, SHP aims to...

Continue Reading